DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,944 | -15.9% | 326,254 | -18.6% | 0.45% | -6.8% |
Q2 2023 | $96,198 | -25.8% | 400,823 | -22.1% | 0.48% | -25.6% |
Q1 2023 | $129,647 | -42.9% | 514,391 | -39.9% | 0.65% | -43.3% |
Q4 2022 | $227,227 | -99.9% | 856,102 | -35.6% | 1.15% | -35.5% |
Q3 2022 | $343,462,000 | -4.7% | 1,329,752 | -6.5% | 1.78% | +6.0% |
Q2 2022 | $360,391,000 | -19.3% | 1,421,550 | -6.6% | 1.68% | +2.3% |
Q1 2022 | $446,652,000 | +4.7% | 1,522,695 | +17.4% | 1.64% | +11.5% |
Q4 2021 | $426,744,000 | +26.7% | 1,297,057 | +17.2% | 1.47% | +17.5% |
Q3 2021 | $336,933,000 | +23.5% | 1,106,729 | +8.8% | 1.25% | +25.4% |
Q2 2021 | $272,906,000 | +185.7% | 1,016,940 | +139.6% | 1.00% | +148.1% |
Q1 2021 | $95,528,000 | +21.8% | 424,414 | +20.2% | 0.40% | +16.5% |
Q4 2020 | $78,451,000 | +1.0% | 353,160 | -2.1% | 0.35% | -10.4% |
Q3 2020 | $77,640,000 | +72.5% | 360,563 | +41.7% | 0.39% | +60.8% |
Q2 2020 | $45,006,000 | +98.4% | 254,520 | +55.3% | 0.24% | +73.9% |
Q1 2020 | $22,687,000 | -71.6% | 163,914 | -68.5% | 0.14% | -65.9% |
Q4 2019 | $79,767,000 | -5.0% | 519,728 | -10.6% | 0.40% | -6.7% |
Q3 2019 | $83,943,000 | +5.4% | 581,203 | +4.3% | 0.43% | -2.0% |
Q2 2019 | $79,625,000 | -21.8% | 557,131 | -27.8% | 0.44% | -22.4% |
Q1 2019 | $101,812,000 | +75.5% | 771,185 | +37.1% | 0.57% | +52.7% |
Q4 2018 | $58,004,000 | +62.0% | 562,485 | +70.7% | 0.37% | +39.6% |
Q3 2018 | $35,806,000 | +5.7% | 329,522 | -4.0% | 0.27% | +0.8% |
Q2 2018 | $33,879,000 | -46.7% | 343,322 | -47.2% | 0.27% | -63.7% |
Q1 2018 | $63,612,000 | +7.1% | 649,698 | +1.5% | 0.73% | +20.2% |
Q4 2017 | $59,395,000 | -24.9% | 639,898 | -30.6% | 0.61% | -21.0% |
Q3 2017 | $79,040,000 | +947.9% | 921,422 | +850.9% | 0.77% | +828.9% |
Q4 2016 | $7,543,000 | -0.4% | 96,900 | +0.3% | 0.08% | 0.0% |
Q3 2016 | $7,572,000 | -42.5% | 96,600 | -25.9% | 0.08% | -44.7% |
Q2 2016 | $13,175,000 | +4.5% | 130,450 | -1.9% | 0.15% | -6.8% |
Q1 2016 | $12,612,000 | -6.6% | 132,950 | -8.6% | 0.16% | -6.9% |
Q4 2015 | $13,509,000 | +24.6% | 145,450 | +14.3% | 0.17% | +22.7% |
Q3 2015 | $10,843,000 | +0.7% | 127,250 | +1.2% | 0.14% | +18.5% |
Q2 2015 | $10,763,000 | +7.9% | 125,750 | +7.1% | 0.12% | +13.3% |
Q1 2015 | $9,972,000 | -0.1% | 117,450 | +0.9% | 0.10% | -7.1% |
Q4 2014 | $9,981,000 | -20.2% | 116,450 | -29.2% | 0.11% | -13.1% |
Q3 2014 | $12,503,000 | -3.0% | 164,550 | +0.5% | 0.13% | +2.4% |
Q2 2014 | $12,892,000 | -83.7% | 163,750 | -84.5% | 0.13% | -84.8% |
Q1 2014 | $79,061,000 | -0.5% | 1,054,150 | +2.4% | 0.83% | -4.1% |
Q4 2013 | $79,489,000 | +11.2% | 1,029,650 | -0.2% | 0.87% | +8.1% |
Q3 2013 | $71,493,000 | +7.0% | 1,031,350 | -2.2% | 0.80% | +10.7% |
Q2 2013 | $66,785,000 | – | 1,055,050 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |